Indirect treatment comparison of cabazitaxel for patients with metastatic castrate-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen.

by Jon P Fryzek, Heidi Reichert, Nicholas Summers, Lindsay Townes, Robert Deuson, Dominik D Alexander, Jackie Vanderpuye-Orgle
Published 2018-01-01